156 related articles for article (PubMed ID: 10972902)
1. Mechanisms of neonatal tolerance induced in an animal model for primary Sjögren's syndrome by intravenous administration of autoantigen.
Saegusa K; Ishimaru N; Haneji N; Yanagi K; Yoneda T; Saito I; Hayashi Y
Scand J Immunol; 2000 Sep; 52(3):264-70. PubMed ID: 10972902
[TBL] [Abstract][Full Text] [Related]
2. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjögren's syndrome.
Saegusa K; Ishimaru N; Yanagi K; Mishima K; Arakaki R; Suda T; Saito I; Hayashi Y
J Immunol; 2002 Jul; 169(2):1050-7. PubMed ID: 12097413
[TBL] [Abstract][Full Text] [Related]
3. Treatment with anti-CD86 costimulatory molecule prevents the autoimmune lesions in murine Sjögren's syndrome (SS) through up-regulated Th2 response.
Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
Clin Exp Immunol; 2000 Feb; 119(2):354-60. PubMed ID: 10632675
[TBL] [Abstract][Full Text] [Related]
4. Anti-120-kDa alpha-fodrin immune response with Th1-cytokine profile in the NOD mouse model of Sjögren's syndrome.
Yanagi K; Ishimaru N; Haneji N; Saegusa K; Saito I; Hayashi Y
Eur J Immunol; 1998 Oct; 28(10):3336-45. PubMed ID: 9808203
[TBL] [Abstract][Full Text] [Related]
5. Autoantigen-specific CD4+CD28low T cell subset prevents autoimmune exocrinopathy in murine Sjögren's syndrome.
Saegusa K; Ishimaru N; Yanagi K; Haneji N; Nishino M; Azuma M; Saito I; Hayashi Y
J Immunol; 2000 Aug; 165(4):2251-7. PubMed ID: 10925313
[TBL] [Abstract][Full Text] [Related]
6. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjögren's syndrome.
Kobayashi M; Yasui N; Ishimaru N; Arakaki R; Hayashi Y
Arthritis Rheum; 2004 Dec; 50(12):3974-84. PubMed ID: 15593201
[TBL] [Abstract][Full Text] [Related]
7. Possible role of organ-specific autoantigen for Fas ligand-mediated activation-induced cell death in murine Sjögren's syndrome.
Ishimaru N; Yanagi K; Ogawa K; Suda T; Saito I; Hayashi Y
J Immunol; 2001 Nov; 167(10):6031-7. PubMed ID: 11698484
[TBL] [Abstract][Full Text] [Related]
8. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
9. Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity.
He J; Zhao J; Li Z
Arthritis Res Ther; 2008; 10(2):R44. PubMed ID: 18419828
[TBL] [Abstract][Full Text] [Related]
10. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
[TBL] [Abstract][Full Text] [Related]
11. Development of autoimmune exocrinopathy resembling Sjögren's syndrome in adoptively transferred mice with autoreactive CD4+ T cells.
Arakaki R; Ishimaru N; Saito I; Kobayashi M; Yasui N; Sumida T; Hayashi Y
Arthritis Rheum; 2003 Dec; 48(12):3603-9. PubMed ID: 14674013
[TBL] [Abstract][Full Text] [Related]
12. Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome.
Miyazaki K; Takeda N; Ishimaru N; Omotehara F; Arakaki R; Hayashi Y
Am J Pathol; 2005 Oct; 167(4):1051-9. PubMed ID: 16192640
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of EBV-mediated alpha-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome.
Inoue H; Tsubota K; Ono M; Kizu Y; Mizuno F; Takada K; Yamada K; Yanagi K; Hayashi Y; Saito I
J Immunol; 2001 May; 166(9):5801-9. PubMed ID: 11313424
[TBL] [Abstract][Full Text] [Related]
14. Alpha-fodrin as a putative autoantigen in Graves' ophthalmopathy.
Kahaly GJ; Bang H; Berg W; Dittmar M
Clin Exp Immunol; 2005 Apr; 140(1):166-72. PubMed ID: 15762888
[TBL] [Abstract][Full Text] [Related]
15. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
16. Novel fragments of the Sjögren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death.
Nagaraju K; Cox A; Casciola-Rosen L; Rosen A
Arthritis Rheum; 2001 Oct; 44(10):2376-86. PubMed ID: 11665980
[TBL] [Abstract][Full Text] [Related]
17. Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.
Saegusa K; Ishimaru N; Yanagi K; Arakaki R; Ogawa K; Saito I; Katunuma N; Hayashi Y
J Clin Invest; 2002 Aug; 110(3):361-9. PubMed ID: 12163455
[TBL] [Abstract][Full Text] [Related]
18. Neonatal exposure to low-dose 2,3,7,8-tetrachlorodibenzo-p-dioxin causes autoimmunity due to the disruption of T cell tolerance.
Ishimaru N; Takagi A; Kohashi M; Yamada A; Arakaki R; Kanno J; Hayashi Y
J Immunol; 2009 May; 182(10):6576-86. PubMed ID: 19414813
[TBL] [Abstract][Full Text] [Related]
19. [Mucosal administration of alpha-fodrin inhibits experimental Sjögren's syndrome autoimmunity].
He J; Zhao JX; Wang H; Li ZG
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(9):625-9. PubMed ID: 18646720
[TBL] [Abstract][Full Text] [Related]
20. The epitope study of alpha-fodrin autoantibody in primary Sjögren's syndrome.
Chen Q; Li X; He W; Zhang H; Gao A; Cheng Y; Lei J; Li S; Zeng L
Clin Exp Immunol; 2007 Sep; 149(3):497-503. PubMed ID: 17614976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
